Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Aversa

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapseFranco Aversa, Adelmo Terenzi, Antonio Tabilio, et al.
American Journal of Hematology|July 19, 2016
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective surveyEnrico Maria Trecarichi, Livio Pagano, Bruno Martino, et al.
Pharmacological Research|October 2, 2017
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitorsMonia Savi, Caterina Frati, Stefano Cavalli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Alfonso Piciocchi, et al.
Blood Advances|January 4, 2018
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamideFranco Aversa, Esther Bachar-Lustig, Noga Or-Geva, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Graft engineering for allogeneic haploidentical stem cell transplantationAntonio Tabilio, Franca Falzetti, Tiziana Zei, et al.
Blood|June 14, 2014
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapseMassimo F Martelli, Mauro Di Ianni, Loredana Ruggeri, et al.
Expert Review of Hematology|December 30, 2017
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disordersAlessandro Busca, Simone Cesaro, Luciana Teofili, et al.
Haematologica|January 7, 2017
<i>IL21R</i> expressing CD14<sup>+</sup>CD16<sup>+</sup> monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Low PD-1 Expression in Cytotoxic CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive ValueGiulia Mazzaschi, Denise Madeddu, Angela Falco, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapseFranco Aversa, Adelmo Terenzi, Antonio Tabilio, et al.
American Journal of Hematology|July 19, 2016
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective surveyEnrico Maria Trecarichi, Livio Pagano, Bruno Martino, et al.
Pharmacological Research|October 2, 2017
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitorsMonia Savi, Caterina Frati, Stefano Cavalli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Alfonso Piciocchi, et al.
Blood Advances|January 4, 2018
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamideFranco Aversa, Esther Bachar-Lustig, Noga Or-Geva, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Graft engineering for allogeneic haploidentical stem cell transplantationAntonio Tabilio, Franca Falzetti, Tiziana Zei, et al.
Blood|June 14, 2014
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapseMassimo F Martelli, Mauro Di Ianni, Loredana Ruggeri, et al.
Expert Review of Hematology|December 30, 2017
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disordersAlessandro Busca, Simone Cesaro, Luciana Teofili, et al.
Haematologica|January 7, 2017
<i>IL21R</i> expressing CD14<sup>+</sup>CD16<sup>+</sup> monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Low PD-1 Expression in Cytotoxic CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive ValueGiulia Mazzaschi, Denise Madeddu, Angela Falco, et al.
Pageof 16